Literature DB >> 22228181

Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways.

Ju Hee Kim1, Seongeun Kang, Tae Woo Kim, Lihong Yin, Ran Liu, Sun Jung Kim.   

Abstract

Epigenetic methylation change is a major process that occurs during cancer development. Even though many tumor-related genes have been identified based on their relationship between methylation and expression, few studies have been conducted to investigate the relevant biological pathways involved in these changes. To identify essential pathways likely to be affected by methylation in breast cancer, we examined a pool of genes in which expression was upregulated after induction of demethylation by 5-Aza-2'-deoxycytidine (Aza) in the MCF-7 breast cancer cell line. Genome-wide demethylation was confirmed by monitoring the demethylation of a previously known gene, SULT1A1. Overall, 210 and 213 genes were found to be upregulated and downregulated (fold change ≥ 2), respectively, in common in cells treated with 5 and 10 μM of Aza. Network analysis of these 423 genes with altered expression patterns identified the involvement of a cancer related network of genes that were heavily regulated by TNF-α in breast tumorigenesis. Our results suggest that epigenetic dysregulation of cellular processes relevant to TNF-α-dependent apoptosis may be intimately involved in tumorigenesis in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228181      PMCID: PMC3887717          DOI: 10.1007/s10059-012-2182-8

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  36 in total

Review 1.  DNA methylation and cancer.

Authors:  Marta Kulis; Manel Esteller
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer.

Authors:  Tae Woo Kim; Yoo Jung Kim; Hyun Ji Lee; Sun Young Min; Han-Sung Kang; Sun Jung Kim
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

3.  Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.

Authors:  Yongmei Yin; Xiaofeng Chen; Yongqian Shu
Journal:  Biomed Pharmacother       Date:  2009-06-13       Impact factor: 6.529

4.  Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene.

Authors:  Huihua Xiong; Hong Qiu; Liang Zhuang; Hua Xiong; Rui Jiang; Yuan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

5.  Array-based DNA methylation profiling for breast cancer subtype discrimination.

Authors:  Ilse Van der Auwera; Wayne Yu; Liping Suo; Leander Van Neste; Peter van Dam; Eric A Van Marck; Patrick Pauwels; Peter B Vermeulen; Luc Y Dirix; Steven J Van Laere
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

6.  Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis.

Authors:  Qian Zhang; Hong Y Wang; Gauri Bhutani; Xiaobin Liu; Michele Paessler; John W Tobias; Donald Baldwin; Kunchithapadam Swaminathan; Michael C Milone; Mariusz A Wasik
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

7.  The expression analysis of periostin in human breast cancer.

Authors:  Yanan Zhang; Guangyuan Zhang; Junsheng Li; Qingsong Tao; Wenhao Tang
Journal:  J Surg Res       Date:  2009-02-27       Impact factor: 2.192

8.  Widespread and tissue specific age-related DNA methylation changes in mice.

Authors:  Shinji Maegawa; George Hinkal; Hyun Soo Kim; Lanlan Shen; Li Zhang; Jiexin Zhang; Nianxiang Zhang; Shoudan Liang; Lawrence A Donehower; Jean-Pierre J Issa
Journal:  Genome Res       Date:  2010-01-27       Impact factor: 9.043

Review 9.  The multifaceted role of periostin in tumorigenesis.

Authors:  Kai Ruan; Shideng Bao; Gaoliang Ouyang
Journal:  Cell Mol Life Sci       Date:  2009-03-24       Impact factor: 9.261

10.  Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.

Authors:  Bo Hwa Sohn; In Young Park; Jung Ju Lee; Suk-Jin Yang; Ye Jin Jang; Kyung Chan Park; Dong Joon Kim; Dong Chul Lee; Hyun Ahm Sohn; Tae Woo Kim; Hyang-Sook Yoo; Jong Young Choi; Yun Soo Bae; Young Il Yeom
Journal:  Gastroenterology       Date:  2009-12-29       Impact factor: 22.682

View more
  5 in total

1.  A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genes.

Authors:  Hae-Seok Eo; Jee Yeon Heo; Yongjin Choi; Youngdon Hwang; Hyung-Seok Choi
Journal:  Mol Cells       Date:  2012-09-13       Impact factor: 5.034

2.  Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer.

Authors:  J F Hiken; J I McDonald; K F Decker; C Sanchez; J Hoog; N D VanderKraats; K L Jung; M Akinhanmi; L E Rois; M J Ellis; J R Edwards
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

3.  Transcriptome analysis of human colorectal cancer biopsies reveals extensive expression correlations among genes related to cell proliferation, lipid metabolism, immune response and collagen catabolism.

Authors:  Lai Xu; Rong Wang; Joseph Ziegelbauer; Wells W Wu; Rong-Fong Shen; Hartmut Juhl; Yaqin Zhang; Lorraine Pelosof; Amy S Rosenberg
Journal:  Oncotarget       Date:  2017-08-18

4.  Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines.

Authors:  Mariama El Baroudi; Dario La Sala; Caterina Cinti; Enrico Capobianco
Journal:  Theor Biol Med Model       Date:  2014-05-07       Impact factor: 2.432

Review 5.  MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.

Authors:  Lavinia Raimondi; Angela De Luca; Eugenio Morelli; Gianluca Giavaresi; Pierosandro Tagliaferri; Pierfrancesco Tassone; Nicola Amodio
Journal:  Biomed Res Int       Date:  2016-01-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.